CEMI NASDAQ
Chembio Diagnostics, Inc.
1W: +1.1%
1M: +16.4%
3M: +30.0%
1Y: -27.4%
3Y: -96.5%
5Y: -94.2%
$0.46
Last traded 2023-04-27 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
By Geography
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$48M
+30.9% ▲
5Y CAGR: +15.0%
Gross Profit
$10M
+301.6% ▲
5Y CAGR: -2.5%
Operating Income
-$20M
+15.0% ▲
Net Income
-$23M
+31.3% ▲
EPS (Diluted)
$-0.96
+31.4% ▲
EBITDA
-$15M
+30.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $33M | $34M | $30M | $37M | $48M |
| YoY Growth | +39.1% | +3.2% | -11.6% | +21.3% | +30.9% |
| Cost of Revenue | $21M | $22M | $24M | $34M | $39M |
| Gross Profit | $12M | $12M | $7M | $2M | $10M |
| Gross Margin | 35.9% | 35.0% | 21.6% | 6.6% | 20.2% |
| R&D Expenses | $9M | $9M | $10M | $12M | $7M |
| SG&A Expenses | $11M | $16M | $21M | $25M | $24M |
| Operating Expenses | $20M | $25M | $29M | $26M | $30M |
| Operating Income | -$8M | -$13M | -$22M | -$24M | -$20M |
| Operating Margin | -22.9% | -36.6% | -72.1% | -65.0% | -42.2% |
| Interest Expense | $0 | $847M | $3M | $3M | $382K |
| Income Before Tax | -$8M | -$14M | -$26M | -$34M | -$23M |
| Tax Expense | -$68K | -$500K | -$457K | -$62K | $34K |
| Net Income | -$8M | -$14M | -$26M | -$34M | -$23M |
| Net Margin | -23.5% | -39.7% | -83.8% | -91.8% | -48.2% |
| EPS (Diluted) | $-0.54 | $-0.81 | $-1.34 | $-1.40 | $-0.96 |
| EBITDA | -$7M | -$861M | -$19M | -$21M | -$15M |
| Shares Outstanding | 14M | 17M | 19M | 24M | 24M |